Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model.
about
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablationPioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillationEffects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model.Effect of High-dose Telmisartan on the Prevention of Recurrent Atrial Fibrillation in Hypertensive PatientsAngiotensin II receptor blockers in the prevention of atrial fibrillation.Mechanisms of termination and prevention of atrial fibrillation by drug therapy.Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases.Effect of Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers on patients following ablation of atrial fibrillationDirect action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium.Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data.Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation.The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model.
P2860
Q26864767-1BCC488A-26EC-416E-BC81-8ED30BDA2231Q34388593-F3F0268F-32F8-4361-AF62-518240F47AA7Q34559487-05D3DDD8-0F76-4FEB-9F4C-0F0C885FA324Q36316380-7EA00817-F183-4578-BD7C-8B4799715B94Q36964621-351216DE-E201-4B8D-9AEC-61E03C508F2FQ37114614-52AC4BB9-26AF-47F5-B3FD-BD0EF488D056Q37494662-F2830DE0-C8E2-40A7-9972-2621DA87618DQ37844891-F80A963F-E5C4-4AEE-B2EF-94FAF2186EFEQ37868371-9D24A7D3-A4D1-4C1B-8F6C-CEB3E8CAAF46Q39168875-19237BF8-3005-4F03-A75D-11AEBC48B97EQ42214235-3104DDB9-1BEA-436D-86B9-9D23DFFC32BFQ45933335-47C95950-A522-4A50-9F21-FA5ADAB16809Q50510208-C8FCAD59-54A1-4034-9498-29CC34BD2DEAQ50746227-4F70D2F1-4F81-42EC-9F4D-7251C5A22BCCQ51007042-AFB0F4DC-EF3E-4693-A361-C87B73879976Q51649021-CAF5DA1D-6FF4-4462-B90D-E5D6D7899027Q53139064-D23D3D70-1B17-41BA-AB8E-B3415CBD2DB9Q53820825-EBC733BF-7EF7-41B3-82FF-B5106EE8BAED
P2860
Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@en
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@nl
type
label
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@en
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@nl
prefLabel
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@en
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@nl
P356
P1433
P1476
Reverse-remodeling effects of ...... ine atrial fibrillation model.
@en
P2093
Hideko Nakashima
Koichiro Kumagai
P304
P356
10.1253/CIRCJ.71.1977
P577
2007-12-01T00:00:00Z